{
    "info": {
        "nct_id": "NCT00050349",
        "official_title": "EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors",
        "criteria": "Inclusion Criteria:\n\n* Patients with biopsy-proven metastatic carcinoid tumors or other neuroendocrine tumors (Islet cell, Gastrinomas and VIPomas) with at least one measurable lesion (other than bone) that has either not been previously irradiated or if previously irradiated has demonstrated progression since the radiation therapy\n* The patient has no major impairment of renal or hepatic function, as defined by the following laboratory parameters: total bilirubin \\<1.5 X ULN; AST, ALT\\<2.5X ULN (\\<5 X ULN if liver metastases are present)\n* Patients on Sandostatin Lar (long acting somatostatin analogue) must be on a stable dose for 30 days prior to study entry and short acting somatostatin analogues must be judged to be on a clinically stable dose by the investigator prior to study entry\n* Must have a life expectancy of greater than three (3) months\n* Karnofsky Performance Status \\> 60\n* Female patients must have a negative serum pregnancy test at screening. (Not applicable to patients with bilateral oophorectomy and/or hysterectomy or to those patients who are postmenopausal.)\n\nExclusion Criteria:\n\n* Patients with symptomatic CNS metastases or leptomeningeal involvement\n* Patients with known brain metastases, unless these metastases have been treated and/or have been stable for at least six months prior to study start. Subjects with a history of brain metastases must have a head CT with contrast to document either response or progression.\n* Patients with bone metastases as the only site(s) of measurable disease\n* Patients with hepatic artery chemoembolization within the last 6 months (one month if there are other sites of measurable disease)\n* Patients who have been previously treated with radioactive directed therapies\n* Patients who have been previously treated with epothilone\n* Patients with any peripheral neuropathy or unresolved diarrhea greater than Grade 1\n* Patients with severe cardiac insufficiency patients taking Coumadin or other warfarin-containing agents with the exception of low dose warfarin (1 mg or less) for the maintenance of in-dwelling lines or ports\n* Patients taking any experimental therapies history of another malignancy within 5 years prior to study entry except curatively treated non-melanoma skin cancer, prostate cancer, or cervical cancer in situ\n* Patients with active or suspected acute or chronic uncontrolled infection including abcesses or fistulae\n* Patients with a medical or psychiatric illness that would preclude study or informed consent and/or history of noncompliance to medical regimens or inability or unwillingness to return for all scheduled visits\n* HIV+ patients\n* Pregnant or lactating females."
    },
    "lines": [
        {
            "line": "* Patients with biopsy-proven metastatic carcinoid tumors or other neuroendocrine tumors (Islet cell, Gastrinomas and VIPomas) with at least one measurable lesion (other than bone) that has either not been previously irradiated or if previously irradiated has demonstrated progression since the radiation therapy",
            "criterions": [
                {
                    "exact_snippets": [
                        "biopsy-proven metastatic carcinoid tumors"
                    ],
                    "criterion": "biopsy-proven metastatic carcinoid tumors",
                    "value": "present"
                },
                {
                    "exact_snippets": [
                        "other neuroendocrine tumors"
                    ],
                    "criterion": "other neuroendocrine tumors",
                    "value": "present"
                },
                {
                    "exact_snippets": [
                        "Islet cell"
                    ],
                    "criterion": "Islet cell tumors",
                    "value": "present"
                },
                {
                    "exact_snippets": [
                        "Gastrinomas"
                    ],
                    "criterion": "Gastrinomas",
                    "value": "present"
                },
                {
                    "exact_snippets": [
                        "VIPomas"
                    ],
                    "criterion": "VIPomas",
                    "value": "present"
                },
                {
                    "exact_snippets": [
                        "at least one measurable lesion"
                    ],
                    "criterion": "measurable lesion",
                    "value": "at least one"
                },
                {
                    "exact_snippets": [
                        "other than bone"
                    ],
                    "criterion": "measurable lesion location",
                    "value": "other than bone"
                },
                {
                    "exact_snippets": [
                        "not been previously irradiated"
                    ],
                    "criterion": "lesion irradiation status",
                    "value": "not been previously irradiated"
                },
                {
                    "exact_snippets": [
                        "previously irradiated",
                        "demonstrated progression since the radiation therapy"
                    ],
                    "criterion": "lesion progression post-irradiation",
                    "value": "progression since radiation therapy"
                }
            ]
        },
        {
            "line": "* The patient has no major impairment of renal or hepatic function, as defined by the following laboratory parameters: total bilirubin \\<1.5 X ULN; AST, ALT\\<2.5X ULN (\\<5 X ULN if liver metastases are present)",
            "criterions": [
                {
                    "exact_snippets": [
                        "no major impairment of renal or hepatic function"
                    ],
                    "criterion": "major impairment of renal or hepatic function",
                    "value": "no"
                },
                {
                    "exact_snippets": [
                        "total bilirubin <1.5 X ULN"
                    ],
                    "criterion": "total bilirubin",
                    "value": "<1.5 X ULN"
                },
                {
                    "exact_snippets": [
                        "AST, ALT<2.5X ULN"
                    ],
                    "criterion": "AST, ALT",
                    "value": "<2.5X ULN"
                },
                {
                    "exact_snippets": [
                        "<5 X ULN if liver metastases are present"
                    ],
                    "criterion": "AST, ALT if liver metastases are present",
                    "value": "<5 X ULN"
                }
            ]
        },
        {
            "line": "* Patients on Sandostatin Lar (long acting somatostatin analogue) must be on a stable dose for 30 days prior to study entry and short acting somatostatin analogues must be judged to be on a clinically stable dose by the investigator prior to study entry",
            "criterions": [
                {
                    "exact_snippets": [
                        "Patients on Sandostatin Lar (long acting somatostatin analogue)"
                    ],
                    "criterion": "Use of Sandostatin Lar",
                    "value": "Yes"
                },
                {
                    "exact_snippets": [
                        "must be on a stable dose for 30 days prior to study entry"
                    ],
                    "criterion": "Stable dose of Sandostatin Lar",
                    "value": "30 days"
                },
                {
                    "exact_snippets": [
                        "short acting somatostatin analogues"
                    ],
                    "criterion": "Use of short acting somatostatin analogues",
                    "value": "Yes"
                },
                {
                    "exact_snippets": [
                        "must be judged to be on a clinically stable dose by the investigator prior to study entry"
                    ],
                    "criterion": "Clinically stable dose of short acting somatostatin analogues",
                    "value": "Judged by investigator"
                }
            ]
        },
        {
            "line": "* Must have a life expectancy of greater than three (3) months",
            "criterions": [
                {
                    "exact_snippets": [
                        "life expectancy"
                    ],
                    "criterion": "life expectancy",
                    "value": "greater than three (3) months"
                }
            ]
        },
        {
            "line": "* Karnofsky Performance Status \\> 60",
            "criterions": [
                {
                    "exact_snippets": [
                        "Karnofsky Performance Status"
                    ],
                    "criterion": "Karnofsky Performance Status",
                    "value": "> 60"
                }
            ]
        },
        {
            "line": "* Patients with symptomatic CNS metastases or leptomeningeal involvement",
            "criterions": [
                {
                    "exact_snippets": [
                        "symptomatic CNS metastases"
                    ],
                    "criterion": "CNS metastases",
                    "value": "symptomatic"
                },
                {
                    "exact_snippets": [
                        "leptomeningeal involvement"
                    ],
                    "criterion": "leptomeningeal involvement",
                    "value": "present"
                }
            ]
        },
        {
            "line": "* Patients with known brain metastases, unless these metastases have been treated and/or have been stable for at least six months prior to study start. Subjects with a history of brain metastases must have a head CT with contrast to document either response or progression.",
            "criterions": [
                {
                    "exact_snippets": [
                        "known brain metastases"
                    ],
                    "criterion": "Presence of brain metastases",
                    "value": "known"
                },
                {
                    "exact_snippets": [
                        "metastases have been treated"
                    ],
                    "criterion": "Treatment of brain metastases",
                    "value": "treated"
                },
                {
                    "exact_snippets": [
                        "stable for at least six months prior to study start"
                    ],
                    "criterion": "Stability of brain metastases",
                    "value": "stable for at least six months"
                },
                {
                    "exact_snippets": [
                        "history of brain metastases"
                    ],
                    "criterion": "History of brain metastases",
                    "value": "history"
                },
                {
                    "exact_snippets": [
                        "head CT with contrast"
                    ],
                    "criterion": "Head CT with contrast",
                    "value": "required"
                },
                {
                    "exact_snippets": [
                        "document either response or progression"
                    ],
                    "criterion": "Documentation of response or progression",
                    "value": "response or progression"
                }
            ]
        },
        {
            "line": "* Patients with bone metastases as the only site(s) of measurable disease",
            "criterions": [
                {
                    "exact_snippets": [
                        "bone metastases"
                    ],
                    "criterion": "site of measurable disease",
                    "value": "bone metastases"
                }
            ]
        },
        {
            "line": "* Patients with hepatic artery chemoembolization within the last 6 months (one month if there are other sites of measurable disease)",
            "criterions": [
                {
                    "exact_snippets": [
                        "hepatic artery chemoembolization"
                    ],
                    "criterion": "Hepatic artery chemoembolization",
                    "value": "within the last 6 months"
                },
                {
                    "exact_snippets": [
                        "hepatic artery chemoembolization",
                        "one month if there are other sites of measurable disease"
                    ],
                    "criterion": "Hepatic artery chemoembolization with other sites of measurable disease",
                    "value": "within the last 1 month"
                }
            ]
        },
        {
            "line": "* Patients who have been previously treated with radioactive directed therapies",
            "criterions": [
                {
                    "exact_snippets": [
                        "previously treated with radioactive directed therapies"
                    ],
                    "criterion": "previous treatment with radioactive directed therapies",
                    "value": "yes"
                }
            ]
        },
        {
            "line": "* Patients who have been previously treated with epothilone",
            "criterions": [
                {
                    "exact_snippets": [
                        "previously treated with epothilone"
                    ],
                    "criterion": "previous treatment with epothilone",
                    "value": "yes"
                }
            ]
        },
        {
            "line": "* Patients with any peripheral neuropathy or unresolved diarrhea greater than Grade 1",
            "criterions": [
                {
                    "exact_snippets": [
                        "any peripheral neuropathy"
                    ],
                    "criterion": "peripheral neuropathy",
                    "value": "any"
                },
                {
                    "exact_snippets": [
                        "unresolved diarrhea greater than Grade 1"
                    ],
                    "criterion": "unresolved diarrhea",
                    "value": "greater than Grade 1"
                }
            ]
        },
        {
            "line": "* Patients with severe cardiac insufficiency patients taking Coumadin or other warfarin-containing agents with the exception of low dose warfarin (1 mg or less) for the maintenance of in-dwelling lines or ports",
            "criterions": [
                {
                    "exact_snippets": [
                        "severe cardiac insufficiency"
                    ],
                    "criterion": "cardiac insufficiency",
                    "value": "severe"
                },
                {
                    "exact_snippets": [
                        "taking Coumadin or other warfarin-containing agents"
                    ],
                    "criterion": "use of warfarin-containing agents",
                    "value": "taking"
                },
                {
                    "exact_snippets": [
                        "low dose warfarin (1 mg or less)"
                    ],
                    "criterion": "dose of warfarin",
                    "value": "1 mg or less"
                }
            ]
        },
        {
            "line": "* Patients taking any experimental therapies history of another malignancy within 5 years prior to study entry except curatively treated non-melanoma skin cancer, prostate cancer, or cervical cancer in situ",
            "criterions": [
                {
                    "exact_snippets": [
                        "Patients taking any experimental therapies"
                    ],
                    "criterion": "Taking experimental therapies",
                    "value": "Yes"
                },
                {
                    "exact_snippets": [
                        "history of another malignancy within 5 years prior to study entry"
                    ],
                    "criterion": "History of another malignancy",
                    "value": "Within 5 years prior to study entry"
                },
                {
                    "exact_snippets": [
                        "except curatively treated non-melanoma skin cancer"
                    ],
                    "criterion": "Curatively treated non-melanoma skin cancer",
                    "value": "Yes"
                },
                {
                    "exact_snippets": [
                        "except curatively treated",
                        "prostate cancer"
                    ],
                    "criterion": "Curatively treated prostate cancer",
                    "value": "Yes"
                },
                {
                    "exact_snippets": [
                        "except curatively treated",
                        "cervical cancer in situ"
                    ],
                    "criterion": "Curatively treated cervical cancer in situ",
                    "value": "Yes"
                }
            ]
        },
        {
            "line": "* Patients with active or suspected acute or chronic uncontrolled infection including abcesses or fistulae",
            "criterions": [
                {
                    "exact_snippets": [
                        "active or suspected acute or chronic uncontrolled infection"
                    ],
                    "criterion": "infection status",
                    "value": "active or suspected acute or chronic uncontrolled"
                },
                {
                    "exact_snippets": [
                        "abcesses"
                    ],
                    "criterion": "presence of abcesses",
                    "value": "present"
                },
                {
                    "exact_snippets": [
                        "fistulae"
                    ],
                    "criterion": "presence of fistulae",
                    "value": "present"
                }
            ]
        },
        {
            "line": "* Patients with a medical or psychiatric illness that would preclude study or informed consent and/or history of noncompliance to medical regimens or inability or unwillingness to return for all scheduled visits",
            "criterions": [
                {
                    "exact_snippets": [
                        "medical or psychiatric illness"
                    ],
                    "criterion": "medical or psychiatric illness",
                    "value": "that would preclude study or informed consent"
                },
                {
                    "exact_snippets": [
                        "history of noncompliance to medical regimens"
                    ],
                    "criterion": "history of noncompliance to medical regimens",
                    "value": "noncompliance"
                },
                {
                    "exact_snippets": [
                        "inability or unwillingness to return for all scheduled visits"
                    ],
                    "criterion": "inability or unwillingness to return for all scheduled visits",
                    "value": "inability or unwillingness"
                }
            ]
        },
        {
            "line": "* HIV+ patients",
            "criterions": [
                {
                    "exact_snippets": [
                        "HIV+ patients"
                    ],
                    "criterion": "HIV status",
                    "value": "Positive"
                }
            ]
        },
        {
            "line": "* Pregnant or lactating females.",
            "criterions": [
                {
                    "exact_snippets": [
                        "Pregnant"
                    ],
                    "criterion": "Pregnancy status",
                    "value": "Pregnant"
                },
                {
                    "exact_snippets": [
                        "lactating"
                    ],
                    "criterion": "Lactation status",
                    "value": "Lactating"
                }
            ]
        }
    ],
    "failed": [
        {
            "line": "Inclusion Criteria:",
            "criterions": []
        },
        {
            "line": "* Female patients must have a negative serum pregnancy test at screening. (Not applicable to patients with bilateral oophorectomy and/or hysterectomy or to those patients who are postmenopausal.)",
            "criterions": [
                {
                    "exact_snippets": [
                        "Female patients"
                    ],
                    "criterion": "Gender",
                    "value": "Female"
                },
                {
                    "exact_snippets": [
                        "negative serum pregnancy test"
                    ],
                    "criterion": "Serum pregnancy test result",
                    "value": "Negative"
                },
                {
                    "exact_snippets": [
                        "Not applicable to patients with bilateral oophorectomy"
                    ],
                    "criterion": "Bilateral oophorectomy status",
                    "value": "Not applicable"
                },
                {
                    "exact_snippets": [
                        "Not applicable to patients with",
                        "hysterectomy"
                    ],
                    "criterion": "Hysterectomy status",
                    "value": "Not applicable"
                },
                {
                    "exact_snippets": [
                        "Not applicable to patients who are postmenopausal"
                    ],
                    "criterion": "Menopausal status",
                    "value": "Postmenopausal"
                }
            ]
        },
        {
            "line": "Exclusion Criteria:",
            "criterions": []
        }
    ]
}